What New Centre for Advanced Genomics and Precision Medicine Has AIIMS Jammu Launched?
Click to start listening
Synopsis
Discover how AIIMS Jammu's new Centre for Advanced Genomics and Precision Medicine is transforming cancer care in India with affordable, personalized treatment options and state-of-the-art technology. This groundbreaking initiative promises to enhance patient outcomes and accessibility.
Key Takeaways
- AIIMS Jammu has launched a new Centre for Advanced Genomics and Precision Medicine.
- The Centre aims to make affordable precision cancer care accessible to all.
- Utilizes advanced Next Generation Sequencing technology for genomic profiling.
- Partnership with 4baseCare enhances treatment personalization.
- Focus on addressing rare diseases and improving prenatal health.
Jammu, April 28 (NationPress) The All-India Institute of Medical Sciences (AIIMS) Jammu has officially inaugurated the Centre for Advanced Genomics and Precision Medicine, aiming to enhance affordable, precision-oriented cancer treatment through state-of-the-art Next Generation Sequencing (NGS) technology.
Developed in partnership with 4baseCare, the Centre features the Illumina NextSeq 2000 sequencing machine, which provides extensive genomic profiling for individuals battling cancer.
This innovative technology allows healthcare professionals to formulate highly customized, targeted treatment strategies tailored to the individual molecular profiles of patients. AIIMS Jammu revealed its collaboration with 4baseCare earlier this year in January.
“When we treat a patient, we are also caring for their family members. This collaboration reflects our commitment to every family that enters our facility, ensuring they receive the highest quality of care,” stated Prof (Dr) Shakti Kumar Gupta, Executive Director and CEO of AIIMS Jammu.
According to Dr. Sudharshan Elangovan, Vice President – Global Operations at 4baseCare, “By merging advanced genomic insights with AI-enhanced diagnostics, the Centre is set to greatly enhance early disease identification, optimize treatment options, and reduce ineffective therapies, ultimately improving patient outcomes and their quality of life.”
Historically, access to such high-level genomic testing has been financially out of reach for numerous patients. However, this new initiative aims to provide premium NGS-based tests at more accessible prices, fostering inclusivity in precision oncology throughout India.
Reinforcing its position as a national referral center, the Centre will accept samples from patients and healthcare providers nationwide, ensuring that advanced molecular diagnostics are available without geographical limitations.
The Centre will primarily concentrate on targeted, biomarker-centric therapies, creating personalized treatment plans to enhance the outcomes and quality of life for cancer patients.
Moreover, the facility intends to address rare diseases through genomic approaches. To promote healthier pregnancies, it will also incorporate cutting-edge genetic technologies, including Non-Invasive Prenatal Testing (NIPT), Preimplantation Genetic Screening (PGS), and Preimplantation Genetic Diagnosis (PGD).
Point of View
The establishment of the Centre for Advanced Genomics and Precision Medicine at AIIMS Jammu is a significant step forward in enhancing cancer care in India. By making advanced genomic technology accessible, it showcases a commitment to improving health outcomes for all citizens, regardless of their financial background. This initiative reflects a growing recognition of the importance of personalized medicine in tackling complex health challenges.
NationPress
02/05/2025
Frequently Asked Questions
What is the purpose of the Centre for Advanced Genomics?
The Centre aims to enhance affordable, precision-driven cancer care through advanced genomic profiling and targeted therapies.
How does NGS technology benefit cancer treatment?
NGS technology allows for comprehensive genomic profiling, enabling clinicians to develop personalized treatment plans based on each patient's unique molecular profile.
Who is collaborating with AIIMS Jammu for this initiative?
AIIMS Jammu has partnered with 4baseCare to develop and operate the Centre for Advanced Genomics and Precision Medicine.
Will the Centre serve patients nationwide?
Yes, the Centre will accept samples from patients and healthcare providers across India to ensure widespread access to advanced diagnostics.
What other services will the Centre provide?
In addition to cancer care, the Centre will also focus on addressing rare diseases and improving prenatal health through technologies like NIPT, PGS, and PGD.
